TITLE

International Stem Cell Corp Announces Changes to Streamline Management Team

PUB. DATE
May 2011
SOURCE
Biomedical Market Newsletter;5/16/2011, p74
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the management changes at International Stem Cell Corp. (ISCO). It states that Brian Lundstrom has entered into a new contract which allows him to exclusively focus on therapeutic development and international partnering programs in areas outside the U.S. such as China and India. It adds that ISCO chief executive officer (CEO) Andrey Semechkin will combine the duties of company president and CEO and will assume responsibility for business operations in the U.S.
ACCESSION #
60871469

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics